Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3004588	s-prot-fr	— (—)	28296	68297	99.99%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Neurological diseases, wide definition

1071

1266

4.42

319.96

2.1

2.4

—

Small fibre neuropathy

494

784

10.25

307.65

2.4

2.6

—

Cerebrovascular diseases (FINNGEN)

1702

3961

3.22

307.65

2.1

2.4

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

849

873

7.84

307.65

2.2

2.8

—

Disorders of calcium metabolism

763

1711

5.74

307.65

4.1

2.5

—

Complications of surgical and medical care, not elsewhere classified

5946

21816

1.90

307.65

2.3

2.5

—

2.00

—

Anaemias

1747

999

12.67

307.65

2.5

1.3

—

L04AD Calcineurin inhibitors

951

2430

4.65

307.65

2.7

2.6

—

Type 2 diabetes, wide definition

4926

16293

2.01

307.65

2.1

2.7

—

2.00

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

1591

3230

3.73

307.65

2.4

—

Disorders of mineral metabolism

894

2225

4.93

307.65

3.7

2.4

—

Diabetic nephropathy, excluding more controls

1401

3690

3.65

307.65

2.0

2.2

—

Care involving dialysis

1010

2105

6.40

307.65

2.7

2.3

—

Non-Hodgkin lymphoma, all, including Hilmo

1398

3915

4.36

307.65

2.7

1.5

—

Secondary hypertension

733

1304

6.63

307.65

2.0

2.3

—

Disorders of thyroid, IBD co-morbidities

782

1117

5.08

307.36

2.1

2.6

—

Hypothyroidism (congenital or acquired)

858

1029

4.86

298.90

2.5

1.3

—

Hypothyroidism and >3 levothyroxin purchases

851

1025

4.85

295.57

2.5

1.3

—

Hypothyroidism, levothyroxine purchases

851

1025

4.85

295.57

2.5

1.3

—

Diabetes mellitus

5354

17824

1.80

294.10

2.1

2.6

—

2.00

—

Diabetes, varying definitions

5332

17830

1.80

292.67

2.1

2.6

—

2.00

—

Any reimbursement code in KELA

2183

4425

2.56

287.40

2.4

1.6

—

Extracorporeal dialysis

692

1638

5.51

285.92

2.8

2.5

—

Atrial fibrillation and flutter

1608

3774

2.92

285.25

2.6

2.4

—

Type 2 diabetes

5243

17616

1.79

281.98

2.1

2.6

—

2.00

—

Other CVD (FINNGEN)

908

1853

4.25

281.93

3.0

2.4

—

Complications of medical and surgical care

4356

22288

1.84

275.30

2.5

—

2.00

—

Insulin medication

3658

16359

1.95

273.47

2.2

2.6

—

2.00

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

3748

16128

1.94

266.08

2.2

2.7

—

2.00

—

Diseases of the musculoskeletal system and connective tissue

2236

4773

2.43

265.37

2.3

—

ILD medications: azathioprine

900

2617

3.78

264.29

1.8

1.6

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

223

178

53.33

261.56

12.9

1.3

—

Neurological diseases

3935

10695

1.91

254.46

2.2

2.6

—

2.00

—

Depression medications

869

1049

4.31

253.27

1.8

1.3

—

Intracranial trauma

2673

8787

2.13

251.61

2.3

2.6

—

2.00

—

Atrial fibrillation and flutter with reimbursement

1410

3256

2.92

246.45

2.6

2.4

—

Diabetic nephropathy

1412

5570

2.90

245.40

2.0

2.2

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

4938

17426

1.74

244.51

2.1

2.6

—

2.00

—

Complications of procedures, not elsewhere classified

4503

21440

1.76

243.45

2.2

2.5

—

2.00

—

Other antidepressants

5446

16943

1.70

237.72

2.2

2.5

—

2.00

—

Preparatory care for dialysis

532

1204

6.00

234.83

2.3

2.7

—

Disorders resulting from impaired renal tubular function

458

926

6.81

230.65

2.3

2.6

—

Secondary and unspecified malignant neoplasm of lymph nodes

776

2311

3.98

227.17

1.9

1.5

—

Malignant immunoproliferative diseases

248

287

24.30

225.31

11.6

2.4

—

Insulin, combination of fast acting with intermediate-acting or long-acting

3661

19260

1.81

217.94

2.2

2.5

—

2.00

—

Nephrotic syndrome

370

649

7.75

215.49

2.7

2.6

—

Myelodysplastic syndrome, including Hilmo

412

809

7.15

215.14

2.8

1.5

—

Concussion

2286

8741

2.10

214.11

2.2

2.6

—

2.00

—

Type 2 diabetes, definitions combined

4872

17392

1.68

213.60

2.1

2.6

—

2.00

—

Kidney transplant status

495

1118

5.48

213.41

1.9

2.7

—

Hypothyroidism, drug reimbursement

541

795

5.01

212.18

2.5

1.3

—

Type 2 diabetes, strict (exclude DM1)

4892

17527

1.68

211.50

2.1

2.6

—

2.00

—

Diabetes, insulin treatment (Kela reimbursement)

5312

19915

1.64

210.65

2.1

2.6

—

2.00

—

Dizziness and giddiness

4186

19652

1.72

208.15

2.2

2.5

—

2.00

—

Hypo-osmolality and hyponatraemia

1328

5482

2.65

206.05

2.6

2.3

—

Insulin, intermediate and long-acting

3274

18163

1.83

203.72

2.1

2.5

—

2.00

—

Isolated proteinuria

343

602

7.79

199.95

3.1

2.7

—

Type 2 diabetes, definitions combined, including avohilmo

4778

17285

1.65

193.24

2.1

2.6

—

2.00

—

Sleep apnoea

5026

20257

1.62

190.05

2.2

2.5

—

2.00

—

Diabetes medication

5201

19477

1.61

189.98

2.0

2.6

—

2.00

—

Hypertensive Renal Disease

432

976

5.64

187.94

2.2

2.8

—

Dialysis

388

810

6.02

184.37

2.3

2.4

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3465

20417

1.74

183.02

2.3

2.5

—

2.00

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

149

112

65.68

181.48

14.2

1.3

—

Amyloidosis

330

626

7.72

180.46

7.1

2.5

—

Amyloidosis, other/unspecified

298

519

9.04

180.05

7.6

2.5

—

Other disorders involving the immune mechanism, not elsewhere classified

339

649

6.78

178.63

2.8

2.6

—

Diffuse large B-cell lymphoma, including Hilmo

505

1377

4.59

171.54

1.8

1.5

—

Diffuse large B-cell lymphoma, helper endpoint

505

1377

4.59

171.54

1.8

1.5

—

Diffuse large B-cell lymphoma

505

1377

4.59

171.54

1.8

1.5

—

Chronic lower respiratory diseases

5850

20681

1.53

169.20

2.2

2.5

—

2.00

—

Sleep apnoea, including avohilmo

5119

20351

1.57

169.18

2.2

2.5

—

2.00

—

Hyperkalaemia

573

1708

4.01

168.23

2.5

2.4

—

Non-Hodgkin lymphoma, all

470

1248

4.69

165.31

3.4

1.5

—

Other disorders of white blood cells

504

1401

4.36

164.75

2.3

2.6

—

Other nutritional deficiencies

3293

18448

1.69

157.29

1.9

2.5

—

2.00

—

Anaemia in chronic diseases classified elsewhere

295

572

7.02

155.20

2.0

2.7

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

304

599

6.50

154.90

2.4

2.6

—

Abnormal findings on examination of urine, without diagnosis

423

1094

4.75

153.48

3.0

2.5

—

Acute myeloid leukaemia and myelodysplastic syndromes

293

600

6.57

144.93

2.1

1.5

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

4475

23256

1.54

143.67

2.9

2.3

—

2.00

—

Acquired haemolytic anaemia

296

626

6.44

141.67

3.4

2.5

—

Giant cell arteritis

434

1225

4.46

140.86

1.8

2.8

—

Other (not insulin) diabetes medications

4833

19124

1.52

140.66

2.1

2.6

—

2.00

—

Chronic lymphocytic leukaemia

342

816

5.49

140.51

2.5

1.5

—

Chronic lymphocytic leukaemia, helper endpoint

342

816

5.49

140.51

2.5

1.5

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

342

816

5.49

140.51

2.5

1.5

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3154

19799

1.65

139.17

2.2

2.5

—

2.00

—

Haemolytic anaemias

344

824

5.21

138.61

3.2

2.5

—

Other dialysis

317

726

5.64

136.33

2.3

2.8

—

Volume depletion

723

2744

2.93

136.32

2.2

2.4

—

Obesity and other hyperalimentation

3032

17883

1.65

132.68

1.9

2.5

—

2.00

—

Vasculitis limited to skin, not elsewhere classified

295

656

5.89

131.94

2.1

2.6

—

Obesity

3013

17798

1.65

131.84

1.9

2.5

—

2.00

—

Marginal zone B-cell lymphoma, including Hilmo

220

391

8.25

128.70

2.5

1.5

—

Chronic nephritic syndrome

353

915

4.72

127.60

2.6

2.7

—

Other and unspecified disorders of white blood cells

373

1008

4.52

127.37

2.3

2.7

—

IgA nephropathy (IgA glomerulonephritis)

250

495

6.56

127.25

1.8

2.5

—

Myelodysplastic syndrome

197

320

9.45

126.72

2.5

1.4

—

Missing teeth due to accident, extraction or parodontitis

3463

20342

1.58

124.20

2.5

—

2.00

—

Depression or dysthymia

3258

11280

1.62

123.56

2.3

2.6

—

2.00

—

Other and unspecified vasculitis limited to skin

266

578

6.04

122.36

2.2

2.6

—

Fibromyalgia

515

1714

3.27

121.58

2.3

—

Temporal arteritis

377

1073

4.43

121.12

1.7

2.8

—

Factors influencing health status and contact with health services

1308

3128

2.17

120.52

2.5

2.0

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

991

4583

2.35

120.21

2.0

1.5

—

Mood disorders, excluding more controls

4429

17890

1.49

116.86

2.2

2.5

—

2.00

—

Biguanides

4672

19649

1.47

115.82

2.0

2.6

—

2.00

—

Drug-induced osteoporosis with pathological fracture

231

487

7.00

113.22

1.8

2.8

—

Other specified/unspecified systemic involvement of connective tissue

409

1265

3.70

111.64

1.9

2.9

—

Asthma/COPD (KELA code 203)

4436

20673

1.47

110.77

2.1

2.5

—

2.00

—

Other autoimmune haemolytic anaemias

183

321

8.80

109.59

3.1

2.5

—

Asthma, including avohilmo

5543

22087

1.41

108.28

2.2

2.5

—

2.00

—

Other diseases of pericardium

362

1062

3.97

107.99

2.1

2.5

—

Giant cell arteritis with polymyalgia rheumatica

377

1165

4.05

107.08

1.7

2.7

—

Diabetic retinopathy, excluding more controls

1505

4527

1.98

106.62

2.0

2.2

—

Viral hepatitis, IBD co-morbidity

204

379

5.73

105.49

2.0

2.5

—

Hypoparathyroidism

331

960

4.19

102.18

2.3

2.5

—

Cardiomyopathy in other diseases

113

128

17.25

100.90

8.0

2.0

—

Other abnormal findings of blood chemistry

370

1152

3.71

100.49

3.3

2.6

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

372

1187

3.76

98.88

2.9

2.8

—

Systemic lupus erythematosus

288

770

4.42

98.82

1.9

2.7

—

Any operation in hilmo

116

24.55

98.37

2.3

1.4

—

Other and unspecified diseases of blood and blood-forming organs

257

670

4.78

92.97

4.6

2.6

—

Fungal Sepsis

347

1102

3.67

91.76

3.6

2.3

—

Diseases of pulp and periapical tissues, including avohilmo

4835

18173

1.40

91.09

2.4

—

2.00

—

Rare circulating lymphoid malignancy, including Hilmo

247

639

4.63

89.04

4.5

1.5

—

Implicit fungal Sepsis

323

1007

3.75

88.13

3.8

2.3

—

Dental caries, including avohilmo

3617

12909

1.47

86.76

2.3

2.4

—

2.00

—

Rheumatism, unspecified

725

3362

2.31

86.53

2.1

2.6

—

SLE, ICD10

274

785

4.13

85.36

1.9

2.5

—

SLE, strict definition

274

785

4.13

85.36

1.9

2.5

—

Caries of dentine, including avohilmo

3821

13794

1.45

85.26

2.3

2.4

—

2.00

—

Cytomegalovirus infection, IBD co-morbidity

207

487

5.24

85.23

6.0

2.5

—

Marginal zone B-cell lymphoma

134

219

9.04

85.23

2.0

1.3

—

Isolated proteinuria with specified morphological lesion

144

254

8.03

84.43

3.4

2.7

—

Substance abuse, excluding more controls

2538

14119

1.54

83.81

1.8

2.5

—

2.00

—

Endocarditis

280

823

3.95

83.34

2.3

—

Other/unspecified cytomegaloviral diseases

185

410

5.66

82.32

6.4

2.6

—

Cytomegaloviral disease

208

504

5.04

82.27

6.0

2.4

—

Cytomegaloviral disease, including avohilmo

208

506

5.00

81.76

6.0

2.4

—

Mood [affective] disorders

4597

21751

1.38

81.44

2.2

2.5

—

2.00

—

Mood disorders

4606

21771

1.38

81.21

2.2

2.5

—

2.00

—

Systemic lupus erythematosus, unspecified

239

663

4.29

78.18

1.8

2.4

—

Other abnormalities of plasma proteins

173

386

5.86

77.29

4.5

2.8

—

Intracranial injury

2807

18198

1.47

75.56

2.2

2.4

—

2.00

—

Idiopathic thrombocytopenic purpura

242

697

4.09

74.78

2.6

2.5

—

Carpal tunnel syndrome

2896

17596

1.46

74.16

2.3

2.5

—

2.00

—

Hepatomegaly and splenomegaly, not elsewhere classified

116

186

8.55

74.07

2.3

3.1

—

Early onset COPD, excluding more controls

955

5164

1.93

73.07

1.9

2.0

—

Eosinophilic disease (BM)

138

262

6.51

72.78

2.3

1.9

—

Motor neuron disease ALS

173

402

5.19

71.92

1.4

2.9

—

Motor neuron disease (with DMD)

173

406

5.10

70.87

1.4

2.8

—

Depression

4149

20636

1.37

70.77

2.2

2.5

—

2.00

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

115

193

8.26

70.52

6.3

2.5

—

Non-allergic asthma (mode), excluding more controls

796

4102

2.00

68.13

2.2

1.9

—

Charcot foot

161

372

5.32

67.82

2.1

3.1

—

Hodgkin lymphoma, hilmo

209

595

4.09

65.42

1.8

2.7

—

Other and unspecified immunodeficiencies with predominantly antibody defects

123

236

6.72

64.89

4.3

2.4

—

Other disorders of adrenal gland

286

991

3.22

64.23

2.5

2.6

—

Trochanteric bursitis

756

4031

1.98

61.28

2.2

2.6

—

Conductive and sensorineural hearing loss

3873

19404

1.35

60.74

2.5

—

2.00

—

Diabetic neuropathy

745

3996

2.02

60.51

2.1

2.2

—

Coxibs

1249

3913

1.72

59.62

2.1

2.4

—

Adrenocortical insufficiency

249

837

3.38

59.47

2.6

2.7

—

Pneumocystosis

185

529

4.39

59.31

6.7

2.7

—

Pneumocystosis, including avohilmo

185

529

4.39

59.31

6.7

2.7

—

Disorder of lipoprotein metabolism, unspecified

740

3985

1.98

58.80

2.2

2.4

—

Drug-induced neutropenia

442

1982

2.45

58.68

2.9

2.7

—

Prurigo nodularis

206

629

3.89

58.66

2.0

2.9

—

2615

16788

1.42

58.35

1.8

2.5

—

2.00

—

Diseases of spleen

162

423

4.68

58.34

2.0

2.5

—

Anxiety (asthma-related co-morbidities)

2242

11843

1.47

58.32

2.0

2.4

—

2.00

—

Oxicams

1129

3774

1.76

58.31

2.3

2.4

—

Failure and rejection of transplanted organs and tissues

120

246

6.03

58.30

6.9

2.9

—

Diabetic retinopathy

1931

8119

1.54

58.24

2.0

2.2

—

Sensorineural hearing loss

3746

18903

1.35

57.71

2.5

—

2.00

—

2717

17119

1.41

57.67

1.8

2.5

—

2.00

—

Other and unspecified aplastic anaemias

113

224

6.46

57.50

2.0

2.9

—

Pericarditis

237

789

3.37

57.27

2.2

—

Myeloid leukaemia

223

727

3.62

57.15

2.1

2.7

—

Cardiomyopathies, Primary/intrinsic

632

3257

2.06

57.00

2.1

2.4

—

Other coagulation defects

400

1734

2.49

56.54

2.5

—

Respiratory insufficiency

470

2182

2.30

55.94

1.8

1.9

—

Mental and behavioural disorders due to psychoactive substance use

2623

17412

1.41

55.85

1.8

2.5

—

2.00

—

Alcohol use disorder, Swedish definition

2479

16186

1.43

55.82

1.8

2.5

—

2.00

—

Nonalcoholic fatty liver disease

512

2466

2.21

55.71

2.0

2.6

—

Injuries to the knee and lower leg

5218

22286

1.28

55.12

2.1

2.5

—

2.00

—

Pneumonia due to other infectious organisms, not elsewhere classified

232

783

3.36

55.09

5.5

2.2

—

Elevated blood glucose level

456

2112

2.32

55.09

2.2

2.4

—

Malignant neoplasm of bone and articular cartilage

100

187

6.95

54.35

8.9

1.3

—

Discitis, unspecified

155

415

4.56

53.97

2.8

2.3

—

Paracetamol or NSAID medication

570

1358

2.17

53.82

2.5

1.9

—

Spondylopathies in diseases classified elsewhere

130

310

5.38

53.47

20.2

2.1

—

L04AC Interleukin inhibitors

322

1296

2.67

53.35

1.8

2.5

—

Substance abuse

2538

17137

1.41

53.27

1.8

2.5

—

2.00

—

Malignant neoplasm of bone and articular cartilage, including Hilmo

145

370

4.63

53.26

8.5

1.4

—

Pyoderma gangrenosum

156

7.76

53.23

2.0

3.0

—

Non-allergic asthma (mode)

796

4453

1.84

52.73

2.2

2.0

—

Cardiomyopathy (excluding other)

645

3450

1.98

52.07

2.1

2.3

—

Injuries to the elbow and forearm

3100

19945

1.36

52.04

2.2

2.4

—

2.00

—

Persons encountering health services for specific procedures, not carried out

418

1912

2.32

51.56

2.3

2.2

—

Acetic acid derivatives and related substances

1219

3896

1.66

50.86

2.1

2.4

—

Viral pneumonia (known virus, not influenza)

213

725

3.38

50.29

7.5

2.6

—

Follicular lymphoma, hilmo

306

1261

2.76

50.17

1.7

2.8

—

Protozoal diseases

226

799

3.28

50.14

6.2

2.7

—

Eosinophilia

138

359

4.67

49.91

2.3

2.7

—

Nonhereditary hypogammaglobulinemia

106

230

5.86

48.72

3.5

2.4

—

Valvular operations

714

4037

1.86

48.08

1.9

2.4

—

Kela reimbursement Agammaglobulinemia (D80-84)

142

7.37

48.01

4.6

2.7

—

Protozoal diseases, including avohilmo

227

827

3.15

47.54

6.2

2.8

—

Systemic atrophies primarily affecting the central nervous system

290

1194

2.72

47.24

2.1

2.7

—

Drug-induced osteoporosis

134

360

4.73

47.15

1.6

2.5

—

Etanercept

312

1312

2.55

47.07

1.8

2.5

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

110

253

5.38

46.85

9.3

1.4

—

Other and unspecified coagulation defects

267

1053

2.75

46.51

2.5

2.6

—

Hypocalcemia

183

600

3.57

46.39

4.9

2.6

—

Mantle cell lymphoma, including Hilmo

126

326

4.75

46.13

2.2

1.3

—

Other metabolic disorders

567

3017

1.96

45.96

3.4

2.2

—

Adalimumab

407

1927

2.22

45.82

1.6

2.4

—

Infection of intervertebral disc (pyogenic)

126

331

4.69

45.25

2.0

2.4

—

Bipolar affective disorders

660

3695

1.84

44.95

1.8

2.4

—

Disorders of muscles

478

2437

2.06

44.24

1.9

2.4

—

Folate deficiency anaemia

110

270

5.22

43.72

2.6

2.7

—

Other specified/unspecified necrotizing vasculopathies

117

298

4.78

43.61

1.9

3.1

—

Acute myeloid leukaemia, helper endpoint

117

299

4.78

43.48

1.6

1.4

—

Acute myeloid leukaemia, including Hilmo

117

299

4.78

43.48

1.6

1.4

—

Acute myeloid leukaemia

117

299

4.78

43.48

1.6

1.4

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

125

8.28

43.16

11.0

1.3

—

Hypersplenism

10.37

42.71

2.0

1.8

—

Other symptoms and signs involving the circulatory and respiratory systems

338

1541

2.34

42.31

2.4

—

Ascites

433

2187

2.13

42.02

1.6

2.5

—

Other and unspecified acquired haemolytic anaemias

231

5.53

41.98

3.0

2.0

—

Drug-induced adrenocortical insufficiency

145

440

3.88

41.72

3.1

2.4

—

Microscopic polyangiitis

159

7.26

40.90

1.5

2.4

—

Amputation of foot

198

732

3.12

40.58

2.4

2.8

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

517

2783

1.94

40.52

3.4

2.2

—

Unspecified nephritic syndrome

158

516

3.53

40.11

2.4

2.6

—

Problems related to lifestyle

429

2180

2.05

39.84

1.8

2.5

—

Myositis

169

574

3.32

39.77

1.8

2.6

—

Primary biliary cholangitis, wide definition

151

482

3.55

39.49

1.6

2.7

—

Fracture of lower leg, including ankle

2400

17814

1.35

39.40

2.0

2.5

—

2.00

—

Asthma and allergy, excluding more controls

357

1673

2.16

39.09

2.4

1.6

—

Malignant neoplasm of urinary organs, including Hilmo

605

3483

1.83

38.76

2.2

1.5

—

Gout due to impairment of renal function

111

301

4.70

38.70

2.6

2.8

—

Neuromuscular dysfunction of bladder

471

2514

1.99

38.61

2.0

2.6

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

535

2978

1.91

38.51

2.1

1.5

—

Alcoholic liver disease

529

2965

1.89

37.27

1.5

2.5

—

Ankylosing spondylitis

377

1879

2.11

37.26

1.8

2.3

—

Panic disorder

465

2474

1.94

37.25

1.8

2.3

—

Crohn disease

523

2903

1.88

37.18

1.6

2.4

—

Mixed connective tissue disease

128

385

3.86

37.13

1.7

2.9

—

Dermatitis due to substances taken internally

273

1207

2.42

37.00

3.8

2.7

—

Phobic anxiety disorders

387

1945

2.04

36.29

2.0

2.2

—

Other specified/unspecified inflammatory spondylopathies

202

782

2.75

36.20

2.1

2.3

—

Mental and behavioural disorders due to alcohol

2158

15489

1.35

36.16

1.8

2.5

—

2.00

—

Vitamin deficiency

260

1144

2.45

35.85

2.3

2.6

—

Vitamin deficiency, wide

260

1144

2.45

35.85

2.3

2.6

—

Polycystic kidney disease

163

579

3.16

35.47

1.9

2.6

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

11.12

35.16

2.5

1.9

—

Diabetic retinopathy, strict definition

875

5025

1.62

35.13

1.8

2.2

—

Acute peritonitis

355

1784

2.14

35.11

2.0

2.6

—

Allergic purpura

167

601

3.06

35.10

1.8

2.5

—

Acute posthaemorrhagic anaemia

207

835

2.72

34.84

2.9

2.7

—

Congenital malformations of the urinary system, including avohilmo

283

1308

2.31

34.42

1.8

2.6

—

Faecal incontinence

482

2690

1.89

34.35

1.9

2.5

—

Fracture of forearm

2344

16153

1.33

34.31

2.2

2.5

—

2.00

—

Abnormal findings on diagnostic imaging of central nervous system

253

1121

2.42

34.24

2.4

2.7

—

Mantle cell lymphoma

210

5.12

34.23

1.7

1.3

—

Asthma and allergy

357

1767

2.04

33.80

2.4

1.7

—

Congenital malformations of the urinary system

266

1210

2.35

33.68

1.8

2.6

—

Essential (haemorrhagic) thrombocythaemia

223

952

2.58

33.40

2.5

1.5

—

Osteonecrosis due to drugs

128

418

3.69

33.27

14.9

2.8

—

Metatarsalgia

411

2199

1.95

33.03

2.3

2.5

—

Other bursopathies

606

3647

1.73

32.72

2.5

—

Other shoulder lesions

397

2110

1.96

32.52

1.6

2.5

—

Acute nephritic syndrome

136

461

3.34

32.31

2.5

2.7

—

Pneumonia derived septicemia

201

832

2.65

32.12

6.4

2.6

—

Polyarteritis nodosa and related conditions

267

4.21

32.09

2.4

2.6

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2147

15882

1.33

31.73

2.4

2.5

—

2.00

—

Primary biliary cholangitis (PBC)

136

465

3.28

31.69

1.8

2.5

—

Intestinal malabsorption

245

1111

2.38

31.56

2.1

2.6

—

Demyelinating diseases of the central nervous system

323

1617

2.09

31.50

1.8

2.3

—

Other enthesopathy of foot (+metatarsalgia)

430

2371

1.89

31.38

2.3

2.5

—

Other encephalitis

162

612

2.93

31.26

2.0

2.6

—

Diseases of inner ear

2516

18918

1.30

31.16

2.4

2.5

—

2.00

—

Cystic kidney disease

181

724

2.75

31.14

1.8

2.7

—

Organ-limited amyloidosis

120

6.83

30.88

4.1

1.7

—

Guillain-Barre syndrome

115

364

3.65

30.87

2.7

2.5

—

Pneumococcal septicemia

191

794

2.64

30.28

6.5

2.6

—

Abnormality of white blood cells, not elsewhere classified

189

4.98

30.28

2.5

2.6

—

Encephalitis

167

654

2.81

29.97

2.0

2.7

—

Cystic kidney disease, including avohilmo

187

773

2.64

29.94

1.8

2.6

—

Drug-induced cataract

150

560

3.01

29.93

3.2

2.6

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

239

4.54

29.69

3.7

2.5

—

Malignant neoplasm of urinary organs

498

2930

1.79

29.67

2.1

1.5

—

Malignant neoplasm of kidney, except renal pelvis

458

2636

1.83

29.56

2.1

1.5

—

Chronic myeloproliferative disease

114

373

3.66

29.52

2.6

2.8

—

Disorders of adult personality and behaviour

883

5909

1.52

29.48

1.9

2.2

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

158

603

2.80

29.33

1.6

2.3

—

Respiratory disorders in diseases classified elsewhere

110

356

3.65

28.82

2.0

2.4

—

Lesion of lateral popliteal nerve

251

1196

2.25

28.59

2.6

2.4

—

Late syphilis

101

312

3.78

28.35

2.0

2.7

—

Secondary thrombocytopenia

298

3.89

28.32

4.0

2.4

—

Pneumonia due to Streptococcus pneumoniae

208

922

2.42

28.20

5.0

2.0

—

Other demyelinating diseases of the central nervous system

160

628

2.73

28.14

1.9

2.4

—

Transport accidents

1662

10385

1.35

27.89

2.0

2.4

—

2.00

—

Pemphigoid

192

844

2.55

27.48

1.5

2.5

—

Late syphilis, including avohilmo

113

380

3.40

27.41

2.1

2.6

—

Hyperhidrosis

131

469

2.97

27.38

1.8

2.5

—

Myocarditis

174

722

2.53

26.89

3.1

2.1

—

Dermatophytosis, including avohilmo

2692

21240

1.26

26.86

2.3

2.4

—

2.00

—

Varicose veins

2747

16712

1.26

26.68

2.4

2.5

—

2.00

—

Acute generalized exanthematous pustulosis

230

1092

2.26

26.53

4.1

2.7

—

Other disorders of nervous system

348

1910

1.94

26.53

2.8

2.6

—

Cramp and spasm

228

1082

2.25

26.22

2.8

2.4

—

Personality disorders

833

5649

1.50

26.15

1.9

2.2

—

Neuralgia and neuritis, unspecified

237

1146

2.19

25.80

2.8

2.6

—

Mature T/NK-cell lymphomas, hilmo

106

360

3.46

25.66

1.4

2.7

—

Other disorders of peripheral nervous system

143

5.35

25.66

3.5

2.7

—

Wegener granulomatosis

315

3.54

25.59

1.8

3.0

—

Exfoliative dermatitis

232

4.09

25.53

1.9

2.7

—

Diabetic maculopathy

617

3758

1.63

25.51

1.7

2.2

—

Hypoglycaemia, other or unspecified

306

1628

1.98

25.38

1.6

2.4

—

Other inflammatory liver diseases

311

1668

1.97

25.33

2.0

2.7

—

Heart failure and hypertrophic cardiomyopathy

134

520

2.96

25.25

2.9

2.8

—

Cryoglobulinemia

16.71

25.21

4.6

1.3

—

Generalized skin eruption due to drugs and medicaments

203

937

2.34

25.21

4.3

2.7

—

Other obstructive and reflux uropathy

181

792

2.42

25.12

1.7

2.2

—

Hypopituitarism

277

1432

2.02

24.80

2.3

2.5

—

Ankylosing spondylitis, ICD10

360

2028

1.86

24.78

1.8

2.5

—

Suppurative and necrotic conditions of lower respiratory tract

301

1615

1.99

24.78

3.0

2.6

—

Hypertrophic cardiomyopathy

236

1169

2.19

24.68

3.0

2.8

—

Xerosis cutis

122

457

3.04

24.45

1.8

2.7

—

Open wound of ankle and foot

439

2634

1.73

24.08

2.3

2.4

—

ILD and respiratory illness in diseases classified elsewhere

135

5.53

24.00

1.5

2.5

—

therapeutic use

192

892

2.37

23.91

2.2

2.7

—

Other/unspecified synovitis and tenosynovitis

457

2774

1.71

23.86

2.0

2.5

—

Other chondrocalcinosis

110

400

3.27

23.85

2.3

2.6

—

125

5.74

23.47

1.5

2.5

—

Barrett oesophagus

267

1405

2.04

23.36

2.4

2.7

—

Hepatic failure, not elsewhere classified

205

984

2.25

23.24

2.1

2.8

—

Malnutrition

132

526

2.79

23.16

2.1

2.5

—

Propionic acid derivatives

1091

3927

1.42

22.90

2.5

2.4

—

Impingement syndrome of shoulder

946

6762

1.43

22.83

2.4

2.6

—

Other nonthrombocytopenic purpura

227

3.97

22.67

2.1

2.3

—

Other follicular disorders

288

1555

1.93

22.67

2.4

—

Vitamin D deficiency

106

380

3.07

22.64

1.6

2.2

—

Allergic bronchopulmonary aspergillosis (ABPA)

8.45

22.61

1.9

2.0

—

Synovial cyst of popliteal space [Baker]

342

1955

1.84

22.60

2.3

2.5

—

Crohn's disease NAS

254

1320

2.02

22.53

1.8

2.4

—

Other lack of coordination

106

384

3.10

22.46

1.8

3.0

—

Anti-inflammatory and antirheumatic products, non-steroids

1087

3927

1.42

22.34

2.7

2.4

—

Cardiac arrest

264

1170

1.99

22.33

2.0

2.4

—

Other/unspecified reactive arthropathies

284

1540

1.94

22.32

2.4

2.5

—

Mental and behavioural disorders due to tobacco

375

2212

1.77

22.10

1.9

2.6

—

Mixed hyperlipidaemia

210

1035

2.18

22.09

1.8

2.4

—

Moderate visual impairment, binocular

181

846

2.33

22.04

1.8

2.3

—

Alcohol-induced chronic pancreatitis

296

1642

1.91

21.81

1.8

2.6

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

510

3244

1.61

21.77

2.0

2.3

—

Smoking dependency

375

2229

1.76

21.51

1.9

2.6

—

Pyothorax

232

1199

2.08

21.48

3.2

2.6

—

Henoch-Schönlein purpura nephritis (HSPN)

7.68

21.47

1.3

2.6

—

Extreme obesity with alveolar hypoventilation

212

1062

2.14

21.41

2.1

2.7

—

Anosmia

231

3.45

21.39

2.8

1.4

—

Mixed and other personality disorders

262

1396

1.95

21.39

2.1

2.2

—

Hypertension, Pulmonary Arterial

191

4.14

21.39

2.0

2.8

—

Other specified/unspecified soft tissue disorders

225

1146

2.08

21.38

2.2

2.5

—

Drug-induced polyneuropathy

213

3.99

21.16

12.1

2.1

—

Syphilis

135

569

2.58

20.86

1.8

2.5

—

Syphilis, including avohilmo

135

569

2.58

20.86

1.8

2.5

—

Specific personality disorders

697

4778

1.49

20.85

1.8

2.3

—

Fenamates

574

2549

1.57

20.76

2.4

—

Haemophagocytic lymphohistiocytosis

14.86

20.72

2.3

1.1

—

Bullous pemphigoid

148

659

2.52

20.71

1.5

2.7

—

Acidosis

130

548

2.62

20.34

2.0

2.5

—

Postprocedural disorders of nervous system

228

1185

1.99

20.07

2.2

—

Trigger finger

557

3694

1.55

19.96

1.9

2.5

—

Explicit fungal Sepsis, including avohilmo

144

4.54

19.84

1.4

2.1

—

Gingival hyperplasia

175

839

2.23

19.80

3.0

2.7

—

Mucosal proctocolitis

442

2790

1.63

19.70

2.1

2.4

—

Disorders of myoneural junction and muscle in diseases classified elsewhere

188

4.07

19.69

1.8

2.6

—

KRA_PSY_EATING, excluding more controls

163

742

2.22

19.63

1.6

2.0

—

Cutaneous lupus erythematosus

136

594

2.51

19.59

2.1

2.7

—

Calcinosis cutis

9.88

19.56

3.7

1.2

—

Agoraphobia

366

2.83

19.46

1.7

2.0

—

Collapsed vertebra, not elsewhere classified

210

3.87

19.43

10.0

2.4

—

Chronic hepatitis, not elsewhere classified

169

807

2.25

19.37

1.6

2.8

—

Alcohol induced polyneuropathy

224

3.67

19.35

1.7

2.6

—

Enteropathic arthropathies

101

382

2.84

19.32

1.6

2.9

—

Primary Sclerosing Cholangitis, IBD and UDCA required

101

383

2.85

19.30

2.2

2.5

—

Alcohol abuse, main dg, excluding more controls

532

3520

1.55

19.22

1.5

2.6

—

Infection due to other mycobacteria, including avohilmo

103

399

2.86

19.20

1.8

2.4

—

Sacroiliitis, not elsewhere classified

151

684

2.30

19.20

1.9

2.1

—

Polyarteritis nodosa

125

4.71

19.11

2.0

2.3

—

Leukaemia of unspecified cell type

227

3.66

19.04

2.9

2.7

—

Paraplegia, diplegia of upper limbs

120

503

2.61

18.91

2.0

2.5

—

Selective deficiency of immunoglobulin G [IgG] subclasses

140

4.51

18.91

2.4

2.3

—

Fall on same level involving ice and snow

2385

19704

1.23

18.84

2.2

2.5

—

2.00

—

Abnormal findings in nipple discharge synovial fluid wound secretions

306

3.13

18.82

2.9

2.4

—

Disorders of phosphorus metabolism and phosphatases

5.60

18.79

2.4

1.7

—

Infection due to other mycobacteria

376

2.90

18.68

1.9

2.4

—

Left bundle-branch block

334

2005

1.74

18.57

1.7

2.4

—

Hypertension, portal

6.45

18.56

1.5

1.9

—

Hypermobility syndrome

154

713

2.24

18.55

2.2

2.3

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

191

973

2.10

18.48

2.1

2.6

—

Iridocyclitis in diseases classified elsewhere

108

436

2.72

18.47

1.9

2.6

—

Emotionally unstable personality disorder

318

1872

1.74

18.45

1.8

2.1

—

Psoriatic arthropathies, ICD10

421

2679

1.63

18.43

2.0

2.6

—

ILD-related respiratory insufficiency

201

1050

2.08

18.40

2.3

2.7

—

Explicit fungal Sepsis

143

4.38

18.34

1.4

2.1

—

Special screening examination for other diseases and disorders

429

2736

1.61

18.20

2.4

2.3

—

Amputation of ankle bones

128

563

2.49

18.19

2.2

2.8

—

Post-traumatic stress disorder

202

1038

1.99

18.19

1.5

2.1

—

Other/unspecified crystal arthropathies

175

4.16

18.15

2.5

2.6

—

Other nutritional anaemias

234

3.47

17.94

2.0

2.3

—

Disorders of magnesium metabolism

190

3.86

17.87

1.5

2.7

—

Other immunodeficiencies

213

3.54

17.86

4.3

2.6

—

Crohn's disease of small intestine

251

1404

1.86

17.75

1.7

2.4

—

Other localized connective tissue disorders

110

457

2.64

17.73

3.1

2.5

—

Psoriasis (vulgaris), strict definition

154

733

2.23

17.72

1.7

2.7

—

Membranous nephropathy

5.55

17.70

2.9

2.6

—

Lupus nephritis

6.86

17.64

1.5

3.7

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

338

2.89

17.63

2.2

2.6

—

Fracture of neck

312

1879

1.75

17.45

2.7

2.4

—

Other psoriatic arthropathies

406

2598

1.62

17.38

2.0

2.6

—

Olecranon bursitis

278

1619

1.80

17.37

2.5

—

Mononeuritis multiplex

7.11

17.36

1.9

2.6

—

Cachexia

5.02

17.33

2.4

2.9

—

MS-disease / Multiple Sclerosis

237

1314

1.87

17.20

1.6

2.3

—

Dermatopolymyositis, unspecified

105

4.97

17.12

4.6

3.2

—

Autoimmune hepatitis

169

3.82

16.98

1.6

2.7

—

Polymyositis

176

3.83

16.87

3.0

2.7

—

Malignant neoplasm of other connective and soft tissue

131

602

2.36

16.71

4.7

1.5

—

Hyperkinetic disorders, excluding more controls

198

964

1.94

16.70

1.3

1.9

—

Carrier of infectious disease

116

506

2.46

16.59

1.6

2.5

—

Systemic disorders of connective tissue in diseases classified elsewhere

6.62

16.51

9.0

2.2

—

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

316

1907

1.69

16.45

1.9

2.3

—

Dissociative [conversion] disorders

129

588

2.29

16.30

1.9

2.4

—

Algoneurodystrophy

126

571

2.33

16.30

1.4

2.5

—

Pollen allergy

455

2966

1.54

16.27

2.5

2.2

—

Clear cell adenocarcinoma of kidney

226

1269

1.89

16.24

1.9

1.5

—

Right bundle-branch block

179

931

2.04

16.22

2.5

2.4

—

Postzoster neuralgia

101

423

2.65

16.18

3.6

2.3

—

Adenocarcinoma and Papillary adenocarcinoma of kidney

260

3.18

16.17

2.9

1.4

—

Tobacco use

222

1237

1.88

16.12

1.7

2.5

—

Drug-induced systemic lupus erythematosus

128

4.31

16.06

1.8

2.3

—

Rare circulating lymphoid malignancy

124

4.44

16.05

3.9

1.4

—

Need for immunization against other single viral diseases

405

2.64

15.96

2.8

2.4

—

Carcinoma in situ of skin of scalp and neck

181

963

2.06

15.93

2.4

2.6

—

Testicular dysfunction

156

776

2.11

15.88

2.1

2.5

—

Necrosis of pulp, including avohilmo

2076

17023

1.22

15.69

2.6

2.4

—

2.00

—

Orthopaedic devices associated with adverse incidents

123

573

2.40

15.64

1.9

2.6

—

Cluster headache, wide

141

680

2.17

15.53

1.7

2.8

—

Hidradenitis suppurativa

126

581

2.27

15.52

2.2

2.3

—

Other or unspecified common variable immunodeficiency

6.23

15.49

2.3

1.8

—

Polycythaemia vera

170

888

2.05

15.40

2.5

1.5

—

Crohn's disease of large intestine

189

1015

1.94

15.37

1.4

2.5

—

Postviral fatigue syndrome

4.70

15.16

1.4

2.6

—

Other and unspecified haemorrhagic conditions

355

2.72

15.15

3.8

2.2

—

Atypical facial pain

214

1203

1.86

15.14

2.8

2.5

—

Deficiency of other B group vitamins

117

537

2.36

15.05

3.2

2.4

—

Other renal tubulo-interstitial diseases

104

451

2.46

15.05

1.7

2.1

—

Artificial opening status

256

1522

1.77

15.03

2.8

2.4

—

Social phobias

199

1086

1.87

15.00

1.9

2.1

—

Testicular hypofunction

139

679

2.15

14.91

2.2

2.5

—

Gangrene, not elsewhere classified

181

3.58

14.78

2.8

2.6

—

Alcohol-induced acute pancreatitis

161

836

2.04

14.74

2.2

2.5

—

Other noninfective disorders of lymphatic vessels and lymph nodes

167

878

2.01

14.72

1.5

2.6

—

Hereditary motor and sensory neuropathy

165

3.64

14.70

1.9

2.4

—

Golimumab

129

616

2.20

14.65

1.9

2.3

—

Mental and behavioural disorders due to opioids

111

497

2.32

14.64

1.6

2.0

—

Livedoid vasculitis

106

4.82

14.62

2.6

3.3

—

Iron deficiency

392

2.50

14.58

2.0

2.5

—

Viral hepatitis

235

1369

1.77

14.50

2.1

2.3

—

Viral hepatitis, including avohilmo

244

1440

1.75

14.36

2.1

2.3

—

Paget disease

136

4.18

14.30

2.0

2.2

—

Fluid overload

5.52

14.18

2.5

1.7

—

Cluster headache, strict

127

612

2.17

14.06

1.7

2.8

—

Common variable immunodeficiency

121

4.14

14.03

2.0

2.5

—

6-mercaptopurine

430

2.39

14.00

1.5

2.8

—

Redundant prepuce, phimosis and paraphimosis

713

5192

1.38

13.99

2.2

2.5

—

Orchitis and epididymitis

382

2534

1.56

13.99

2.5

2.4

—

Total colectomy operation

171

921

1.95

13.96

2.4

2.7

—

Total colectomy

171

921

1.95

13.96

2.4

2.7

—

Other secondary coxarthrosis

164

875

1.99

13.95

1.5

2.5

—

Malignant neoplasm of bone and articular cartilage of limbs

5.65

13.92

3.4

1.4

—

Speech and linguistic disorders, excluding more controls

187

959

1.87

13.92

1.9

2.3

—

Lung transplant status

151

3.72

13.91

1.4

2.5

—

Lung transplantation

151

3.72

13.90

1.4

2.5

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

215

1233

1.79

13.90

1.8

2.5

—

Other disorders of bone density and structure

107

486

2.34

13.90

2.1

2.4

—

Other nonautoimmune haemolytic anaemias

6.91

13.85

5.9

1.3

—

Special screening examination for neoplasms

257

1561

1.70

13.68

2.7

2.3

—

Exposure to other and unspecified inanimate mechanical forces

275

1700

1.67

13.64

2.4

2.5

—

Unspecified contracted kidney

124

4.07

13.61

2.1

—

Plantar fascial fibromatosis

352

2306

1.57

13.57

2.5

2.4

—

Other viral hepatitis, including avohilmo

200

1134

1.82

13.56

2.2

2.3

—

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

4.87

13.52

2.8

2.5

—

Disorders of orbit

186

1040

1.88

13.51

3.3

2.5

—

Adult-onset Still disease

5.50

13.45

1.5

1.7

—

Acute pharyngitis

401

2667

1.51

13.44

3.1

2.1

—

Hypersensitivity angiitis

112

4.29

13.31

1.6

2.6

—

Other Crohn's disease

227

1343

1.74

13.29

1.5

2.3

—

Febrile neutrophilic dermatosis [Sweet]

9.18

13.28

6.4

1.3

—

Listeriosis, including avohilmo

117

4.20

13.28

5.6

2.5

—

Other forms of systemic lupus erythematosus

166

3.47

13.21

1.7

2.7

—

Other viral hepatitis

191

1079

1.83

13.15

2.2

—

Cardiomyopathy, Hypertrophic obstructive

404

2.46

13.14

2.0

2.6

—

Recurrent dislocation and subluxation of joint

183

1018

1.85

13.14

1.8

2.5

—

Brachial plexus disorders

279

1745

1.64

13.09

2.3

2.4

—

Chronic myeloid leukaemia, including Hilmo

183

3.31

13.05

1.4

1.3

—

Background retinopathy and retinal vascular changes

110

523

2.27

13.00

1.9

2.8

—

Other and unspecified psoriasis

287

1821

1.64

12.99

1.9

2.6

—

Acquired pure red cell aplasia [erythroblastopenia]

4.75

12.97

2.9

2.6

—

Panniculitis, unspecified

228

3.02

12.92

2.2

2.8

—

Erythema nodosum

134

685

2.08

12.91

2.6

—

Other prurigo

251

2.92

12.91

1.3

2.9

—

Other and unspecified paralytic syndromes

285

2.75

12.89

3.5

2.8

—

Nail disorders

316

2050

1.59

12.84

2.1

2.4

—

Infarction of spleen

166

3.55

12.80

1.4

2.5

—

Other and unspecified follicular disorders

163

889

1.92

12.79

2.5

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

184

1035

1.82

12.76

1.6

2.1

—

Other and unspecified diseases of spleen

4.58

12.72

2.8

3.4

—

Defects in the complement system

119

3.89

12.68

4.7

2.3

—

Paralytic strabismus

312

2032

1.60

12.67

2.3

2.5

—

Protein-energy malnutrition of moderate and mild degree

232

3.03

12.65

2.2

2.1

—

Universal erythroderma, KELA reimbursement

301

2.69

12.59

1.6

2.9

—

Mental and behavioural disorders due to sedatives or hypnotics

226

1358

1.72

12.54

1.5

2.3

—

Childhood asthma (age<16), excluding more controls

184

798

1.82

12.53

1.6

1.5

—

Chronic iridocyclitis

199

1160

1.79

12.53

2.0

2.6

—

Disorders of purine and pyrimidine metabolism

137

3.77

12.46

2.0

1.6

—

Congenital malformations and deformations of the musculoskeletal system

229

1371

1.70

12.44

1.9

2.2

—

Systemic disorders of connective tissue in diseases classified elsewhere (FG)

11.99

12.35

11.3

3.2

—

Carcinoma in situ of skin of trunk

191

1119

1.83

12.24

3.6

2.6

—

Corticotropin deficiency

191

3.19

12.19

1.5

2.9

—

Unspecified protein-energy malnutrition

144

3.65

12.19

1.6

2.3

—

Crohn disease (strict definition, all UC cases excluded)

175

989

1.84

12.15

1.7

2.4

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

134

697

2.01

12.15

2.0

2.3

—

Lateral epicondylitis

426

2967

1.47

12.10

2.2

2.4

—

Crohn disease (strict definition, require KELA)

207

1227

1.74

12.10

1.7

2.3

—

Biological medicines for asthma

398

2.37

12.07

2.2

2.3

—

Listeriosis

115

4.04

12.05

5.8

2.5

—

Emotional disorders starting during childhood or adolecense, excluding more controls

217

2.77

12.04

1.2

1.7

—

Thrombotic microangiopathy

124

3.80

12.03

2.9

1.9

—

Drug-induced hypoglycaemia without coma

358

2.48

11.92

1.9

2.5

—

Crohn disease (strict definition, require KELA, min 2 HDR)

203

1202

1.74

11.92

1.7

2.3

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

112

556

2.18

11.91

2.2

3.0

—

Disorders of parathyroid gland, other and/or unspecified

196

3.22

11.87

1.8

2.3

—

Childhood asthma (age<16)

184

812

1.79

11.86

1.6

1.5

—

Obsessive-compulsive disorder

152

827

1.88

11.70

1.7

2.1

—

Other specified and unspecified personality disorders

267

1701

1.61

11.67

1.9

2.3

—

Other bullous disorders

130

684

2.03

11.63

3.3

2.6

—

Fibrosis of liver

158

3.38

11.62

1.6

2.2

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

218

1326

1.69

11.57

1.6

2.4

—

Scleritis

272

2.68

11.44

1.7

2.5

—

Causalgia

283

2.61

11.41

1.4

2.5

—

Sweet's syndrome

7.75

11.40

6.4

1.4

—

Urethral stricture

268

1731

1.62

11.38

2.2

2.6

—

Postprocedural disorders of digestive system, not elsewhere classified

150

831

1.91

11.38

1.8

2.7

—

Other/unspecified enthesopathies, not elsewhere classified

321

2148

1.54

11.36

2.0

2.5

—

Cushing syndrome

256

2.76

11.36

2.1

2.4

—

Erythema multiforme

107

530

2.15

11.35

2.7

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Protein electrophoresis panel - Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS